Application of evidence-based urology in improving quality of care

Indian Journal of Urology

Volumn 23, Issue 2, 2007, Pages 91-96

  Panda, Arabind ^a   Dorairajan, L N ^a   Kumar, Santosh ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Evidence based urology; Quality of care; Strength of evidence

Indexed keywords

EID: 34248379192     PISSN: 09701591     EISSN: None     Source Type: Journal    
DOI: 10.4103/0970-1591.32055     Document Type: Article

References (33)

1. st ed. Paras Medical Publisher: Hyderabad; 2006.
2. Streptomycin treatment of pulmonary tuberculosis: A Medical Research Council investigation. BMJ 1948;2:769-82.
3. Williams JK. Understanding evidence-based medicine: A primer. Am J Obstet Gynecol 2001;185:275-8.
4. Evidence-based medicine. A new approach to teaching the practice of medicine. Evidence-Based Medicine Working Group. JAMA 1992;268:2420-5.
5. Lohr KN. Rating the strength of scientific evidence: Relevance for quality improvement programs. Int J Qual Health Care 2004;16:9-18.
6. Emberton M. Evidence based Medicine for urologists. In: Mundy AR, Fitzpatrick JM, Neal DE, editors. The scientific basis of Urology. Taylor and Francis: Oxford: 635-46.
7. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: What it is and what it isn't. BMJ 1996;312:71-2.
8. Centre for Evidence Based Medicine, Oxford, UK. Available from: http://www.cebm.net.
9. Chalmers I, Haynes B. Systematic reviews: Reporting, updating and correcting systematic reviews of the effects of health care. BMJ 1994;309:862-5.
10. Singh JC. Evidence-based urology. Indian J Urol 2005;2:70-3.
11. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomized controlled trials: The QUOROM Statement. Rev Esp Salud Publica 2000;74:107-18.
12. Moher D, Schulz KF, Altman DG; For the CONSORT group. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. Lancet 2001;357:1191-4.
13. Godlee F. The Cochrane collaboration. BMJ 1994;309:969-70.
14. Straus SE, Sackett DL. Using research findings in clinical practice. BMJ 1998;317:339-42.
15. Kumar S. Evidence based Medicine: The new paradigm of clinical decision making. Indian J Urol 2000;17:73-8.
16. Laine L. Evidence-based medicine: Clinical judgment is required. Gastroenterology 2003;124:1726.
17. Wormald R, Oldfield K. Evidence based medicine, the Cochrane Collaboration, and the CONSORT statement. Br J Ophthalmol 1998;82:597-8.
18. Lohr KN, editor. Medicare: A Strategy for quality assurance. Institute of Medicine. National Academy Press: Washington, DC; 1990.
19. Sur RL, Scales CD Jr, Preminger GM, Dahm P. Evidence-based medicine: A survey of American Urological Association members. J Urol 2006;176:1127-34.
20. Field MJ, Lohr KN, editors. Guidelines for clinical practice: From development to use. National Academy Press: Washington, DC; 1992.
21. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 2003;170:530-47.
22. Harris R, Lohr KN. Screening for prostate cancer: An update of the evidence. Ann Intern Med 2002;137:917-29.
23. Osheroff JA, Forsyth DE, Buchanan BG, Bankowitz RA, Blumenfeld BH, Miller RA. Physicians' information needs: Analysis of questions posed during clinical teaching. Ann Int Med 1991;114:576-81.
24. Covell DG, Uman GC, Manning PR. Information needs in office practice: Are they being met? Ann Int Med 1985;103:596-9.
25. Indian Medlars Centre [homepage on the Internet). Available from: http://www.indmed.nic.in.
26. Database of the US National Library of medicine [homepage on the Internet]. Available from: http://www.pubmed.gov.
27. Sauve S, Lee HN, Meade MO, Lang JD, Farkouh M, Cook DJ et al. The critically appraised topic: A practical approach to learning critical appraisal. Ann Roy Soc Phys Surg Canada 1995;28:396-8.
28. Chapple CR, Rechberger T, Al-shukri S, Meffan P, Everaert K, Huang M, et al. Randomized, double-blind placebo and Tolterodine-controlled trial of the once-daily antimuscarinic agent Solifenacin in patients with symptomatic overactive bladder. BJU International 2004;93:303-10.
29. McConnell JD, Roehrborn CC, Bautista OM, Andriole GL, Dixon CM, Kusek JW, et al. The long-term effect of doxazosin, finasteride and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003;349:2387-98.
30. Anonymous. Long term BPH treatment. Bandolier 2004;11:1-4.
31. Nuovo J, Melnikow J, Chang D. Reporting number needed to treat and absolute risk reduction in randomized controlled trials. JAMA 2002;287:2813-4.
32. Schilling LM, Steiner JF, Lundahl K, Anderson RJ. Residents' patient-specific clinical questions: Opportunities for evidence-based learning. Acad Med 2005;80:51-6.
33. Brown A, Kraft D, Schmitz SM, Sharpless V, Martin C, Shah R, et al. Association of industry sponsorship to published outcomes in gastrointestinal clinical research. Clin Gastroenterol Hepatol 2006;4:1445-51.